Federated Hermes’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $197M | Buy |
254,946
+8,327
| +3% | +$6.38M | 0.32% | 72 |
|
|
2025
Q4 | $190M | Buy |
246,619
+10,419
| +4% | +$7.08M | 0.32% | 81 |
|
|
2025
Q3 | $133M | Sell |
236,200
-9,387
| -4% | -$5.31M | 0.23% | 103 |
|
|
2025
Q2 | $129M | Buy |
245,587
+204,045
| +491% | +$114M | 0.24% | 109 |
|
|
2025
Q1 | $26.3M | Buy |
41,542
+5,579
| +16% | +$3.84M | 0.06% | 349 |
|
|
2024
Q4 | $25.6M | Buy |
35,963
+30,304
| +536% | +$25.4M | 0.06% | 361 |
|
|
2024
Q3 | $5.95M | Buy |
5,659
+1,875
| +50% | +$2.09M | 0.01% | 684 |
|
|
2024
Q2 | $3.98M | Sell |
3,784
-6,391
| -63% | -$6.2M | 0.01% | 770 |
|
|
2024
Q1 | $9.79M | Buy |
10,175
+6,961
| +217% | +$6.62M | 0.02% | 574 |
|
|
2023
Q4 | $2.82M | Buy |
3,214
+418
| +15% | +$344K | 0.01% | 859 |
|
|
2023
Q3 | $2.3M | Buy |
2,796
+160
| +6% | +$126K | 0.01% | 877 |
|
|
2023
Q2 | $1.89M | Buy |
2,636
+335
| +15% | +$258K | ﹤0.01% | 972 |
|
|
2023
Q1 | $1.89M | Sell |
2,301
-136
| -6% | -$103K | ﹤0.01% | 976 |
|
|
2022
Q4 | $1.76M | Sell |
2,437
-2,605
| -52% | -$1.92M | ﹤0.01% | 954 |
|
|
2022
Q3 | $3.47M | Buy |
5,042
+371
| +8% | +$234K | 0.01% | 753 |
|
|
2022
Q2 | $2.76M | Buy |
4,671
+1,071
| +30% | +$696K | 0.01% | 848 |
|
|
2022
Q1 | $2.51M | Sell |
3,600
-55
| -2% | -$34.8K | 0.01% | 975 |
|
|
2021
Q4 | $2.31M | Buy |
3,655
+230
| +7% | +$141K | ﹤0.01% | 1006 |
|
|
2021
Q3 | $2.07M | Sell |
3,425
-242
| -7% | -$150K | ﹤0.01% | 1035 |
|
|
2021
Q2 | $2.05M | Buy |
3,667
+141
| +4% | +$71.4K | ﹤0.01% | 1091 |
|
|
2021
Q1 | $1.67M | Sell |
3,526
-922
| -21% | -$449K | ﹤0.01% | 1174 |
|
|
2020
Q4 | $2.15M | Buy |
4,448
+572
| +15% | +$309K | ﹤0.01% | 1038 |
|
|
2020
Q3 | $2.17M | Buy |
3,876
+167
| +5% | +$101K | 0.01% | 956 |
|
|
2020
Q2 | $2.31M | Sell |
3,709
-191,254
| -98% | -$109M | 0.01% | 947 |
|
|
2020
Q1 | $95.2M | Buy |
194,963
+156,470
| +406% | +$64.5M | 0.28% | 76 |
|
|
2019
Q4 | $14.5M | Buy |
38,493
+25,232
| +190% | +$8.49M | 0.03% | 511 |
|
|
2019
Q3 | $3.68M | Sell |
13,261
-1,858
| -12% | -$550K | 0.01% | 854 |
|
|
2019
Q2 | $4.73M | Sell |
15,119
-16,889
| -53% | -$5.62M | 0.01% | 800 |
|
|
2019
Q1 | $13.1M | Buy |
32,008
+12,477
| +64% | +$5.14M | 0.03% | 466 |
|
|
2018
Q4 | $7.29M | Buy |
19,531
+17,234
| +750% | +$6.31M | 0.02% | 620 |
|
|
2018
Q3 | $928K | Sell |
2,297
-221
| -9% | -$84.1K | ﹤0.01% | 1372 |
|
|
2018
Q2 | $868K | Sell |
2,518
-938
| -27% | -$293K | ﹤0.01% | 1330 |
|
|
2018
Q1 | $1.19M | Buy |
3,456
+334
| +11% | +$116K | ﹤0.01% | 1167 |
|
|
2017
Q4 | $1.17M | Sell |
3,122
-196
| -6% | -$79.4K | ﹤0.01% | 1163 |
|
|
2017
Q3 | $1.48M | Sell |
3,318
-800
| -19% | -$381K | ﹤0.01% | 1056 |
|
|
2017
Q2 | $2.02M | Sell |
4,118
-238
| -5% | -$104K | 0.01% | 912 |
|
|
2017
Q1 | $1.69M | Sell |
4,356
-150,015
| -97% | -$55.6M | ﹤0.01% | 979 |
|
|
2016
Q4 | $56.7M | Buy |
154,371
+151,187
| +4,748% | +$57.5M | 0.17% | 118 |
|
|
2016
Q3 | $1.28M | Buy |
3,184
+79
| +3% | +$31.7K | ﹤0.01% | 1027 |
|
|
2016
Q2 | $1.08M | Sell |
3,105
-35
| -1% | -$13.5K | ﹤0.01% | 1075 |
|
|
2016
Q1 | $1.13M | Sell |
3,140
-2,408
| -43% | -$992K | ﹤0.01% | 1046 |
|
|
2015
Q4 | $3.01M | Sell |
5,548
-604
| -10% | -$327K | 0.01% | 719 |
|
|
2015
Q3 | $2.86M | Sell |
6,152
-3,069
| -33% | -$1.65M | 0.01% | 729 |
|
|
2015
Q2 | $4.7M | Buy |
9,221
+1,365
| +17% | +$666K | 0.01% | 626 |
|
|
2015
Q1 | $3.55M | Sell |
7,856
-4,854
| -38% | -$2.06M | 0.01% | 728 |
|
|
2014
Q4 | $5.21M | Sell |
12,710
-108,563
| -90% | -$42.7M | 0.02% | 598 |
|
|
2014
Q3 | $43.7M | Sell |
121,273
-134
| -0.1% | -$44.9K | 0.14% | 140 |
|
|
2014
Q2 | $34.3M | Buy |
121,407
+19,235
| +19% | +$5.7M | 0.11% | 190 |
|
|
2014
Q1 | $30.7M | Buy |
102,172
+10,960
| +12% | +$3.38M | 0.1% | 194 |
|
|
2013
Q4 | $25.1M | Buy |
91,212
+17,170
| +23% | +$4.94M | 0.09% | 216 |
|
|
2013
Q3 | $23.2M | Buy |
74,042
+11,140
| +18% | +$2.93M | 0.09% | 185 |
|
|
2013
Q2 | $14.1M | Buy |
+62,902
| New | +$14.6M | 0.06% | 266 |
|
Other funds holding REGN
VCM
N
Federated Hermes's REGN Position: Q1 2026 in Review
Federated Hermes increased its Regeneron Pharmaceuticals (REGN) stake by 3.4% in Q1 2026, buying an estimated $6.38M and bringing the position to 254,946 shares worth $197M. The position accounts for 0.32% of the portfolio, ranked #72.
Federated Hermes first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Federated Hermes held 254,946 shares of Regeneron Pharmaceuticals worth $197M as of Q1 2026.
- Federated Hermes bought 8,327 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $6.38M.
- Regeneron Pharmaceuticals made up 0.32% of Federated Hermes's portfolio in Q1 2026, its #72 holding.
- Federated Hermes first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.